img

Global Central Nervous System Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Central Nervous System Drugs Market Insights, Forecast to 2034

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
Global Central Nervous System Drugs market is expected to reach to US$ 121020 million in 2024, with a positive growth of %, compared with US$ 115260 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Central Nervous System Drugs industry is evaluated to reach US$ 186780 million in 2029. The CAGR will be 7.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Central Nervous System Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Central Nervous System Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Segment by Type
OTC
Rx Drugs

Segment by Application


Hospital
Retail Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Central Nervous System Drugs plant distribution, commercial date of Central Nervous System Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Central Nervous System Drugs introduction, etc. Central Nervous System Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Central Nervous System Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Central Nervous System Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Central Nervous System Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Central Nervous System Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Central Nervous System Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Central Nervous System Drugs Revenue by Region
2.2.1 Global Central Nervous System Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Central Nervous System Drugs Revenue by Region (2018-2024)
2.2.3 Global Central Nervous System Drugs Revenue by Region (2024-2029)
2.2.4 Global Central Nervous System Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Central Nervous System Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Central Nervous System Drugs Sales by Region
2.4.1 Global Central Nervous System Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Central Nervous System Drugs Sales by Region (2018-2024)
2.4.3 Global Central Nervous System Drugs Sales by Region (2024-2029)
2.4.4 Global Central Nervous System Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Central Nervous System Drugs Sales by Manufacturers
3.1.1 Global Central Nervous System Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Central Nervous System Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Central Nervous System Drugs in 2022
3.2 Global Central Nervous System Drugs Revenue by Manufacturers
3.2.1 Global Central Nervous System Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Central Nervous System Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Central Nervous System Drugs Revenue in 2022
3.3 Global Key Players of Central Nervous System Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Central Nervous System Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Central Nervous System Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Central Nervous System Drugs Sales by Type
4.1.1 Global Central Nervous System Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Central Nervous System Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Central Nervous System Drugs Sales Market Share by Type (2018-2029)
4.2 Global Central Nervous System Drugs Revenue by Type
4.2.1 Global Central Nervous System Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Central Nervous System Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Central Nervous System Drugs Price by Type
4.3.1 Global Central Nervous System Drugs Price by Type (2018-2024)
4.3.2 Global Central Nervous System Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Central Nervous System Drugs Sales by Application
5.1.1 Global Central Nervous System Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Central Nervous System Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Central Nervous System Drugs Sales Market Share by Application (2018-2029)
5.2 Global Central Nervous System Drugs Revenue by Application
5.2.1 Global Central Nervous System Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Central Nervous System Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Central Nervous System Drugs Price by Application
5.3.1 Global Central Nervous System Drugs Price by Application (2018-2024)
5.3.2 Global Central Nervous System Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Central Nervous System Drugs Market Size by Type
6.1.1 US & Canada Central Nervous System Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Central Nervous System Drugs Revenue by Type (2018-2029)
6.2 US & Canada Central Nervous System Drugs Market Size by Application
6.2.1 US & Canada Central Nervous System Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Central Nervous System Drugs Revenue by Application (2018-2029)
6.3 US & Canada Central Nervous System Drugs Market Size by Country
6.3.1 US & Canada Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Central Nervous System Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Central Nervous System Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Central Nervous System Drugs Market Size by Type
7.1.1 Europe Central Nervous System Drugs Sales by Type (2018-2029)
7.1.2 Europe Central Nervous System Drugs Revenue by Type (2018-2029)
7.2 Europe Central Nervous System Drugs Market Size by Application
7.2.1 Europe Central Nervous System Drugs Sales by Application (2018-2029)
7.2.2 Europe Central Nervous System Drugs Revenue by Application (2018-2029)
7.3 Europe Central Nervous System Drugs Market Size by Country
7.3.1 Europe Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Central Nervous System Drugs Sales by Country (2018-2029)
7.3.3 Europe Central Nervous System Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Central Nervous System Drugs Market Size
8.1.1 China Central Nervous System Drugs Sales (2018-2029)
8.1.2 China Central Nervous System Drugs Revenue (2018-2029)
8.2 China Central Nervous System Drugs Market Size by Application
8.2.1 China Central Nervous System Drugs Sales by Application (2018-2029)
8.2.2 China Central Nervous System Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Central Nervous System Drugs Market Size by Type
9.1.1 Asia Central Nervous System Drugs Sales by Type (2018-2029)
9.1.2 Asia Central Nervous System Drugs Revenue by Type (2018-2029)
9.2 Asia Central Nervous System Drugs Market Size by Application
9.2.1 Asia Central Nervous System Drugs Sales by Application (2018-2029)
9.2.2 Asia Central Nervous System Drugs Revenue by Application (2018-2029)
9.3 Asia Central Nervous System Drugs Sales by Region
9.3.1 Asia Central Nervous System Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Central Nervous System Drugs Revenue by Region (2018-2029)
9.3.3 Asia Central Nervous System Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Central Nervous System Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Central Nervous System Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Central Nervous System Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Central Nervous System Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Central Nervous System Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Central Nervous System Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Overview
11.1.3 Biogen Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Biogen Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biogen Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Johnson & Johnson Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 EliLilly
11.6.1 EliLilly Company Information
11.6.2 EliLilly Overview
11.6.3 EliLilly Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 EliLilly Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 EliLilly Recent Developments
11.7 Otsuka
11.7.1 Otsuka Company Information
11.7.2 Otsuka Overview
11.7.3 Otsuka Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Otsuka Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Otsuka Recent Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Overview
11.8.3 Merck Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Merck Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 AstraZeneca Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Takeda
11.11.1 Takeda Company Information
11.11.2 Takeda Overview
11.11.3 Takeda Central Nervous System Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Takeda Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Central Nervous System Drugs Industry Chain Analysis
12.2 Central Nervous System Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Central Nervous System Drugs Production Mode & Process
12.4 Central Nervous System Drugs Sales and Marketing
12.4.1 Central Nervous System Drugs Sales Channels
12.4.2 Central Nervous System Drugs Distributors
12.5 Central Nervous System Drugs Customers
13 Market Dynamics
13.1 Central Nervous System Drugs Industry Trends
13.2 Central Nervous System Drugs Market Drivers
13.3 Central Nervous System Drugs Market Challenges
13.4 Central Nervous System Drugs Market Restraints
14 Key Findings in The Global Central Nervous System Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Central Nervous System Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of OTC
Table 3. Major Manufacturers of Rx Drugs
Table 4. Global Central Nervous System Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Central Nervous System Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Central Nervous System Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Central Nervous System Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Central Nervous System Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Central Nervous System Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Central Nervous System Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Central Nervous System Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global Central Nervous System Drugs Sales by Region (2024-2029) & (K Units)
Table 13. Global Central Nervous System Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Central Nervous System Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Central Nervous System Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Central Nervous System Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Central Nervous System Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Central Nervous System Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Central Nervous System Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Central Nervous System Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Central Nervous System Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Central Nervous System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2022)
Table 23. Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Central Nervous System Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 28. Global Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 29. Global Central Nervous System Drugs Sales Share by Type (2018-2024)
Table 30. Global Central Nervous System Drugs Sales Share by Type (2024-2029)
Table 31. Global Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Central Nervous System Drugs Revenue Share by Type (2018-2024)
Table 34. Global Central Nervous System Drugs Revenue Share by Type (2024-2029)
Table 35. Central Nervous System Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Central Nervous System Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 38. Global Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 39. Global Central Nervous System Drugs Sales Share by Application (2018-2024)
Table 40. Global Central Nervous System Drugs Sales Share by Application (2024-2029)
Table 41. Global Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Central Nervous System Drugs Revenue Share by Application (2018-2024)
Table 44. Global Central Nervous System Drugs Revenue Share by Application (2024-2029)
Table 45. Central Nervous System Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Central Nervous System Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Central Nervous System Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 60. Europe Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 61. Europe Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 62. Europe Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 65. Europe Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 66. Europe Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Central Nervous System Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 72. Europe Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 73. China Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 74. China Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 75. China Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 78. China Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 79. China Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 82. Asia Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 83. Asia Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 86. Asia Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 87. Asia Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Central Nervous System Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Central Nervous System Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Central Nervous System Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Central Nervous System Drugs Sales by Region (2018-2024) & (K Units)
Table 93. Asia Central Nervous System Drugs Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Central Nervous System Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Central Nervous System Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Central Nervous System Drugs Sales by Country (2024-2029) & (K Units)
Table 107. Biogen Company Information
Table 108. Biogen Description and Major Businesses
Table 109. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Biogen Recent Developments
Table 112. Pfizer Company Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Pfizer Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Developments
Table 117. Teva Company Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Teva Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Developments
Table 122. Novartis Company Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Novartis Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novartis Recent Developments
Table 127. Johnson & Johnson Company Information
Table 128. Johnson & Johnson Description and Major Businesses
Table 129. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Johnson & Johnson Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Johnson & Johnson Recent Developments
Table 132. EliLilly Company Information
Table 133. EliLilly Description and Major Businesses
Table 134. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. EliLilly Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. EliLilly Recent Developments
Table 137. Otsuka Company Information
Table 138. Otsuka Description and Major Businesses
Table 139. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Otsuka Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Otsuka Recent Developments
Table 142. Merck Company Information
Table 143. Merck Description and Major Businesses
Table 144. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Merck Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Merck Recent Developments
Table 147. AstraZeneca Company Information
Table 148. AstraZeneca Description and Major Businesses
Table 149. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. AstraZeneca Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. AstraZeneca Recent Developments
Table 152. Novartis Company Information
Table 153. Novartis Description and Major Businesses
Table 154. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Novartis Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Novartis Recent Developments
Table 157. Takeda Company Information
Table 158. Takeda Description and Major Businesses
Table 159. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Takeda Central Nervous System Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Takeda Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Central Nervous System Drugs Distributors List
Table 165. Central Nervous System Drugs Customers List
Table 166. Central Nervous System Drugs Market Trends
Table 167. Central Nervous System Drugs Market Drivers
Table 168. Central Nervous System Drugs Market Challenges
Table 169. Central Nervous System Drugs Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Central Nervous System Drugs Product Picture
Figure 2. Global Central Nervous System Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Central Nervous System Drugs Market Share by Type in 2022 & 2029
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Central Nervous System Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Central Nervous System Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Central Nervous System Drugs Report Years Considered
Figure 11. Global Central Nervous System Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Central Nervous System Drugs Revenue 2018-2029 (US$ Million)
Figure 13. Global Central Nervous System Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Central Nervous System Drugs Revenue Market Share by Region (2018-2029)
Figure 15. Global Central Nervous System Drugs Sales 2018-2029 ((K Units)
Figure 16. Global Central Nervous System Drugs Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Central Nervous System Drugs Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Central Nervous System Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Central Nervous System Drugs Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Central Nervous System Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Central Nervous System Drugs Sales YoY (2018-2029) & (K Units)
Figure 22. China Central Nervous System Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Central Nervous System Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Central Nervous System Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Central Nervous System Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Central Nervous System Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Central Nervous System Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Central Nervous System Drugs in the World: Market Share by Central Nervous System Drugs Revenue in 2022
Figure 29. Global Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 31. Global Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 32. Global Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 33. Global Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Central Nervous System Drugs Revenue Share by Country (2018-2029)
Figure 39. US & Canada Central Nervous System Drugs Sales Share by Country (2018-2029)
Figure 40. U.S. Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 43. Europe Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 44. Europe Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 45. Europe Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 46. Europe Central Nervous System Drugs Revenue Share by Country (2018-2029)
Figure 47. Europe Central Nervous System Drugs Sales Share by Country (2018-2029)
Figure 48. Germany Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. France Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. UK Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. China Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 54. China Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 55. China Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 56. China Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 57. Asia Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 58. Asia Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 59. Asia Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 60. Asia Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Central Nervous System Drugs Revenue Share by Region (2018-2029)
Figure 62. Asia Central Nervous System Drugs Sales Share by Region (2018-2029)
Figure 63. Japan Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. India Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Central Nervous System Drugs Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Central Nervous System Drugs Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Central Nervous System Drugs Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Central Nervous System Drugs Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Central Nervous System Drugs Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Central Nervous System Drugs Sales Share by Country (2018-2029)
Figure 74. Brazil Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Central Nervous System Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Central Nervous System Drugs Value Chain
Figure 80. Central Nervous System Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries